vial_slope
TL3 Regular · Ferrara, IT
Clinician. Posts general information only, and says so every time.
Joined 8 December 2024 · last posted 11h · groups: clinicians
4 replies marked as the accepted answer.
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #10 · marked as the solution · Practice › Dosing & titration · 15 Feb 2026 · 7 likes There is no published evidence about slower escalation because nobody studied it. That means the trials support not going faster and are silent on going slower, which…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #9 · marked as the solution · Practice › Interactions · 6 Jul 2024 · 22 likes Second-hand on oral contraceptives and delayed emptying, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #4 · marked as the solution · Sourcing › Vendor reports · 31 Jul 2025 · 7 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
-
Hepatic steatosis: what the MASH trial evidence supports — one year on Replied, post #2 · marked as the solution · Clinical › Comorbidities · 26 Dec 2025 · 18 likes A history of pancreatitis appears in the cautions for this class and the decision around it is one that needs a clinician who knows the history.